A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that the share of promotional spending allocated to consumer advertising was on average 14.3 percentage points higher for drugs with ...
Feb 7, 2023
0
34
For patients with newly diagnosed multiple myeloma (MM), mass spectrometry (MS) can monitor treatment response, according to a study published online Jan. 4 in Blood Cancer Journal.
Jan 19, 2023
0
18
An international study led by a Rutgers scientist comparing new and older treatments against complicated urinary tract infections has found a new drug combination to be more effective, especially against stubborn, drug-resistant ...
Oct 11, 2022
0
16
Bilateral theta burst stimulation (TBS) is noninferior to standard bilateral repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant depression in older adults, according to a study published online Sept. ...
Sep 28, 2022
0
2
For high-risk patients with mild-to-moderate COVID-19 during the Omicron epoch, bebtelovimab seems to be a reliable treatment option, according to a study published online Sept. 17 in the Journal of Infectious Diseases.
Sep 20, 2022
0
22
In utero exposure to commonly prescribed antipsychotic medications does not seem to meaningfully increase the risk for neurodevelopmental disorders (NDD) in offspring, according to a study published online March 28 in JAMA ...
Mar 31, 2022
0
17
The results from the major phase III OlympiA trial shows the drug improves survival rates in women who have inherited faults in their BRCA1 or BRCA2 genes.
Mar 17, 2022
0
23
The antiviral therapies remdesivir, molnupiravir, and the active ingredient in Pfizer's Paxlovid pill (nirmatrelvir), remain effective in laboratory tests against the BA.2 variant of SARS-CoV-2, the virus that causes COVID-19.
Mar 10, 2022
0
123
(HealthDay)—The addition of subcutaneous tirzepatide versus placebo to titrated insulin glargine results in significant improvements in glycemic control among patients with type 2 diabetes and inadequate glycemic control, ...
Feb 10, 2022
0
2
Current treatments for cystic fibrosis are not suitable for all patients. The lack of treatment options is distressing for people suffering from a rare type of this degenerative and life-threatening disease. But researchers ...
Feb 2, 2022
0
10
